Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenming Chen

Showing results (211-220 of 228) with videos related to

Pageof 23
Sort By:
Cancer Chemotherapy and Pharmacology|May 14, 2017
Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 studyYun Leng, Jian Hou, Jie Jin, et al.
Experimental Hematology & Oncology|October 1, 2025
Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myelomaWenming Chen, Chengcheng Fu, Baijun Fang, et al.
Thrombosis Journal|October 4, 2023
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myelomaXiaozhe Li, Xiuli Sun, Baijun Fang, et al.
Annals of Hematology|February 8, 2019
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registriesVania T M Hungria, Jae Hoon Lee, Angelo Maiolino, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|July 27, 2016
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Mingwei Zhou, et al.
Annals of Hematology|December 19, 2023
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trialHuixing Zhou, Yafei Wang, Jiao Chen, et al.
Frontiers in Endocrinology|November 17, 2022
Expert consensus on the bone repair strategy for osteoporotic fractures in ChinaHao Zhang, Yan Hu, Xiao Chen, et al.
Experimental Hematology & Oncology|July 27, 2023
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic eraTingting Zhang, Weiwei Tian, Shuang Wei, et al.
BMC Psychiatry|June 12, 2024
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort studyXing Luo, Fang Liu, Jin Lu, et al.
Pageof 23

Showing results (211-220 of 228) with videos related to

Sort By:
Pageof 23
Cancer Chemotherapy and Pharmacology|May 14, 2017
Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 studyYun Leng, Jian Hou, Jie Jin, et al.
Experimental Hematology & Oncology|October 1, 2025
Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myelomaWenming Chen, Chengcheng Fu, Baijun Fang, et al.
Thrombosis Journal|October 4, 2023
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myelomaXiaozhe Li, Xiuli Sun, Baijun Fang, et al.
Annals of Hematology|February 8, 2019
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registriesVania T M Hungria, Jae Hoon Lee, Angelo Maiolino, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|July 27, 2016
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Mingwei Zhou, et al.
Annals of Hematology|December 19, 2023
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trialHuixing Zhou, Yafei Wang, Jiao Chen, et al.
Frontiers in Endocrinology|November 17, 2022
Expert consensus on the bone repair strategy for osteoporotic fractures in ChinaHao Zhang, Yan Hu, Xiao Chen, et al.
Experimental Hematology & Oncology|July 27, 2023
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic eraTingting Zhang, Weiwei Tian, Shuang Wei, et al.
BMC Psychiatry|June 12, 2024
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort studyXing Luo, Fang Liu, Jin Lu, et al.
Pageof 23